It is attractive to propose that in GATA2-deficient patients, defective signaling networks attenuate progenitor responsiveness to stress-derived signals, e.g., from pathogens, and responsiveness to other genetic or epigenetic aberrations, thereby causing or contributing to a bone marrow failure and leukemia predisposition. This evidence concerns the gene GATA2 and Bone marrow hypocellularity.